<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-89315" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Extracorporeal Carbon Dioxide Removal</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Titus</surname>
            <given-names>Anoop</given-names>
          </name>
          <aff>Saint Vincent Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sanghavi</surname>
            <given-names>Devang K.</given-names>
          </name>
          <aff>Mayo Clinic</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anoop Titus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Devang Sanghavi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-89315.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Respiratory failure is a frequently encountered condition in the practice of critical care. Life-saving strategies such as mechanical ventilation (MV) are considered when ineffective gaseous exchange occurs, such as severe respiratory insufficiency.<xref ref-type="bibr" rid="article-89315.r1">[1]</xref>&#x000a0;Although of significant benefit, positive-pressure ventilation always carries a risk of developing complications such as oxygen toxicity, lung hyperinflation, ventilator-associated pneumonia, and other complications.<xref ref-type="bibr" rid="article-89315.r2">[2]</xref> In such conditions, when there is a higher demand for gaseous exchange despite the applicable MV settings, extracorporeal membrane oxygenation (ECMO) devices are used to attain physiologic goals.<xref ref-type="bibr" rid="article-89315.r3">[3]</xref></p>
        <p>ECMO devices come in various forms according to the circuit configured and the components forming it. Configurations involving draining the deoxygenated blood from the venous compartment and returning oxygenated-decarboxylated blood to a vein are called venovenous ECMO (VV-ECMO). Similarly, when the blood is configured to return to the artery, it is veno-arterial ECMO (VA-ECMO). Extracorporeal carbon dioxide removal (ECCO2R) devices are specialized ECMO devices that predominantly focus on CO2 removal, thus reducing the&#x000a0;partial pressure of carbon dioxide&#x000a0;(PaCO2) and, eventually, the work of breathing and MV support. The potential advantage of ECCO2R devices is the reduced blood flow through the circuit. The membrane in action is composed of polymethylpentene (PMP) or siloxane.<xref ref-type="bibr" rid="article-89315.r4">[4]</xref> The principle of apnoeic oxygenation&#x000a0;came into being, where oxygenation by the lungs and dependence on the alveoli reduces with independent extracorporeal oxygenation<xref ref-type="bibr" rid="article-89315.r5">[5]</xref>.</p>
        <p>The basis for optional components, such as the pump system in the configuration, depends on the chosen circuit. Arterio-venous ECCO2R circuits do not need the pump in the configuration for functioning, whereas veno-venous ECCO2R requires its need as of the low-pressure system. The use of anticoagulants is necessary to prevent thrombus formation within the circuit.</p>
      </sec>
      <sec id="article-89315.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>ECCO2R&#x000a0;has shown&#x000a0;the possibility of earlier extubation after invasive MV (IMV) insertion. Still, there was no reduction in the length of hospital stay or early mortality (28 days and 90 days).<xref ref-type="bibr" rid="article-89315.r6">[6]</xref></p>
        <p>Complications encountered:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Patient-related challenges:</bold> Bleeding related to vascular access and anticoagulation, hemolysis, heparin-induced thrombocytopenia <xref ref-type="bibr" rid="article-89315.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Circuit and catheter-related challenges:</bold> Vascular injury, vascular occlusion, thrombosis, hematoma, aneurysm, bleeding from the cannula site, kinking&#x000a0;or displacement of the cannulas, and infections (life-threatening)</p>
          </list-item>
          <list-item>
            <p><bold>Mechanical challenges:</bold>&#x000a0;Air embolism, the formation of clots, malfunctioning or failure of the pump, oxygenator, or heat exchange malfunctions</p>
          </list-item>
        </list>
        <p>AV-ECCO2R can cause complications such as distal limb ischemia, compartment syndrome, and pseudoaneurysm formations.<xref ref-type="bibr" rid="article-89315.r8">[8]</xref>&#x000a0;Similar complications occur in the VV system but occur less frequently.</p>
      </sec>
      <sec id="article-89315.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Acute respiratory distress syndrome (ARDS) is associated with significant mortality and morbidity.<xref ref-type="bibr" rid="article-89315.r9">[9]</xref>&#x000a0;Of all patients requiring MV, 23% of the global burden comes from those with ARDS, according to the LUNG SAFE trial. Unfortunately, there is no effective pharmacological treatment for ARDS, which leaves us to continue supported ventilation until the patient recovers. As an appropriate detour away from the expected complications mentioned, newer strategies such as protective and ultraprotective ventilation are used. The first type, protective ventilation, involves small tidal volume and limited plateau pressures; this increased survival yet left behind the complication of lung over-inflation still in the remainder.<xref ref-type="bibr" rid="article-89315.r10">[10]</xref>&#x000a0;Then, the &#x02018;ultra-protective ventilation&#x02019; using very low tidal volume and lower plateau pressures was instilled, adjoining the higher possibility of developing hypercapnia and respiratory acidosis.<xref ref-type="bibr" rid="article-89315.r11">[11]</xref>&#x000a0;These complications are overcome with the ECCO2R device, thus facilitating appropriate lung recovery with ultraprotective settings. Following such strategies has reduced the length of hospital stays of patients.<xref ref-type="bibr" rid="article-89315.r12">[12]</xref></p>
        <p>When considering other pathologies such as chronic obstructive pulmonary disease (COPD), MV can be both noninvasive ventilation (NIV) or IMV, of which the former has shown a better prognosis. Although NIV has proven to reduce mortality by half compared to IMV, one-quarter to one-half of that population eventually requires IMV over time.<xref ref-type="bibr" rid="article-89315.r13">[13]</xref><xref ref-type="bibr" rid="article-89315.r14">[14]</xref>&#x000a0;IMV predisposes to prolonged ventilatory requirements, weaning, and, thus, hospital stay. Of patients on NIV, ECCO2R has prevented the change to IMV in more than half of its cases in certain studies.<xref ref-type="bibr" rid="article-89315.r6">[6]</xref>&#x000a0;The use of ECCO2R in patients requiring IMV allows earlier extubation<bold>.</bold></p>
        <p>Hypercapnia is permissible as it enables the lungs to heal better by reducing inflammation. Hypercapnia becomes problematic with its action in the brain and heart, increasing intracranial pressure (in those with an already high value) and reducing cardiac output (in those with low cardiac function), respectively. Hypercapnoeic failure is one of the common reasons for patient ineligibility for lung transplants. Bridging patients through this phase using ECCO2R has demonstrated promising results.<xref ref-type="bibr" rid="article-89315.r15">[15]</xref></p>
      </sec>
      <sec id="article-89315.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>ECCO2R is not approved by the Food and Drug Administration in the US. Multiple clinical trials are underway to explore its utility in treating chronic obstructive pulmonary disease (COPD) and&#x000a0;acute respiratory distress syndrome (ARDS). Like any extracorporeal device, this is a very resource-intensive and expensive technology. With the potential for complications, there is a need for close monitoring by physicians, nurses, ECMO specialists, and perfusionists with specialized training.&#x000a0;Two other ECCOR2 devices are undergoing&#x000a0;clinical trials, including respiratory dialysis and gas exchange catheters; the former removes the carbon dioxide in wet form using available dialysis equipment, increasing hopes of decreasing the cost and potentially reducing the complication rates.&#x000a0;</p>
      </sec>
      <sec id="article-89315.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=89315&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=89315">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/89315/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=89315">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-89315.s6">
        <title>References</title>
        <ref id="article-89315.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marini</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Mechanical ventilation: past lessons and the near future.</article-title>
            <source>Crit Care</source>
            <year>2013</year>
            <volume>17 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S1</fpage>
            <pub-id pub-id-type="pmid">23514222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neto</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Simonis</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Barbas</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Biehl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Determann</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Elmer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gajic</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Linko</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pinheiro de Oliveira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sundar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Talmor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wolthuis</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Gama de Abreu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pelosi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>MJ</given-names>
              </name>
              <collab>PROtective Ventilation Network Investigators</collab>
            </person-group>
            <article-title>Lung-Protective Ventilation With Low Tidal Volumes and the Occurrence of Pulmonary Complications in Patients Without Acute Respiratory Distress Syndrome: A Systematic Review and Individual Patient Data Analysis.</article-title>
            <source>Crit Care Med</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>10</issue>
            <fpage>2155</fpage>
            <page-range>2155-63</page-range>
            <pub-id pub-id-type="pmid">26181219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peek</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Mugford</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tiruvoipati</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thalanany</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hibbert</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Truesdale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clemens</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Firmin</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Elbourne</surname>
                <given-names>D</given-names>
              </name>
              <collab>CESAR trial collaboration</collab>
            </person-group>
            <article-title>Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>Oct</month>
            <day>17</day>
            <volume>374</volume>
            <issue>9698</issue>
            <fpage>1351</fpage>
            <page-range>1351-63</page-range>
            <pub-id pub-id-type="pmid">19762075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thuys</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Augustin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brizard</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO.</article-title>
            <source>Perfusion</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-23</page-range>
            <pub-id pub-id-type="pmid">15072251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolobow</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pesenti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Solca</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Gattinoni</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A new approach to the prevention and treatment of acute pulmonary insufficiency.</article-title>
            <source>Int J Artif Organs</source>
            <year>1980</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-93</page-range>
            <pub-id pub-id-type="pmid">6767659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braune</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sieweke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brettner</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Staudinger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Joannidis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Verbrugge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Frings</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nierhaus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wegscheider</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kluge</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR&#x000a0;study): multicentre case-control study.</article-title>
            <source>Intensive Care Med</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>9</issue>
            <fpage>1437</fpage>
            <page-range>1437-44</page-range>
            <pub-id pub-id-type="pmid">27456703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sklar</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Beloncle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Katsios</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Brochard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Friedrich</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review.</article-title>
            <source>Intensive Care Med</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>1752</fpage>
            <page-range>1752-62</page-range>
            <pub-id pub-id-type="pmid">26109400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kluge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Braune</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nierhaus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frings</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ebelt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Uhrig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Metschke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wegscheider</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suttorp</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rousseau</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation.</article-title>
            <source>Intensive Care Med</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>10</issue>
            <fpage>1632</fpage>
            <page-range>1632-9</page-range>
            <pub-id pub-id-type="pmid">22836139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>A&#x000f1;&#x000f3;n</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Santos-Bouza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blanch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ambr&#x000f3;s</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gand&#x000ed;a</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carriedo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mosteiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Basald&#x000fa;a</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Kacmarek</surname>
                <given-names>RM</given-names>
              </name>
              <collab>ALIEN Network</collab>
            </person-group>
            <article-title>The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation.</article-title>
            <source>Intensive Care Med</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>12</issue>
            <fpage>1932</fpage>
            <page-range>1932-41</page-range>
            <pub-id pub-id-type="pmid">21997128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serpa Neto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nagtzaam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Ventilation with lower tidal volumes for critically ill patients without the acute respiratory distress syndrome: a systematic translational review and meta-analysis.</article-title>
            <source>Curr Opin Crit Care</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-32</page-range>
            <pub-id pub-id-type="pmid">24275571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hager</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hayden</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
              <collab>ARDS Clinical Trials Network</collab>
            </person-group>
            <article-title>Tidal volume reduction in patients with acute lung injury when plateau pressures are not high.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2005</year>
            <month>Nov</month>
            <day>15</day>
            <volume>172</volume>
            <issue>10</issue>
            <fpage>1241</fpage>
            <page-range>1241-5</page-range>
            <pub-id pub-id-type="pmid">16081547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;nhofer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Euteneuer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>K&#x000f6;hler</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Survival of mechanically ventilated patients admitted to a specialised weaning centre.</article-title>
            <source>Intensive Care Med</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>908</fpage>
            <page-range>908-16</page-range>
            <pub-id pub-id-type="pmid">12122529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinnell</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Pilsworth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shneerson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation.</article-title>
            <source>Chest</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>129</volume>
            <issue>1</issue>
            <fpage>133</fpage>
            <page-range>133-9</page-range>
            <pub-id pub-id-type="pmid">16424423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoo</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Hakimian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santiago</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Hypercapnic respiratory failure in COPD patients: response to therapy.</article-title>
            <source>Chest</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>169</fpage>
            <page-range>169-77</page-range>
            <pub-id pub-id-type="pmid">10631216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-89315.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schellongowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Riss</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Staudinger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ullrich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Krenn</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Sitzwohl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bojic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wohlfarth</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sperr</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Rabitsch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Aigner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Taghavi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jaksch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Klepetko</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Extracorporeal CO2 removal as bridge to lung transplantation in life-threatening hypercapnia.</article-title>
            <source>Transpl Int</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-304</page-range>
            <pub-id pub-id-type="pmid">25387861</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
